Acelyrin Operating Income

Acelyrin posts a operating income of $-290M as of March 2025. That compares with $-330M in the prior-year period — up 9.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Acelyrin's operating income was $-330M. The latest reading is $-290M — a 9.7% year-over-year increase (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

Operating Income is one piece of Acelyrin's financial statement story. At $-290M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SLRN's operating income usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Acelyrin's other metric pages and overview cover the third.